| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |